AstraZeneca’s vaccine has reached phase three clinical trials

AstraZeneca’s vaccine has reached phase three clinical trials.Report says it shows potential immune response in the trials.
Astrazeneca or also called AZD1222 or ChAdOx1 nCoV-19.Developed by Oxford University.
India’s Serum Institute partnered with oxford university said it will price the shot at $3 per dose in india.